Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)

Market Cap	105.44B -6.4%
Revenue (ttm)	8.78B +21.2%
Net Income	2.40B +32.7%
EPS	104.27 +32.7%
Shares Out	23.03M
PE Ratio	43.91
Forward PE	37.90
Dividend	75.00 (1.64%)
Ex-Dividend Date	n/a

Volume	7,400
Average Volume	18,110
Open	4,505.00
Previous Close	4,578.10
Day's Range	4,505.00 - 4,698.00
52-Week Range	3,975.00 - 5,894.50
Beta	n/a
RSI	60.62
Earnings Date	Apr 30, 2026

About NSE:SANOFICONR

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited is a subsidiary of Opella Healthcare Participations B.V.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2023
• Employees: 583
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SANOFICONR

Financial Performance

In 2025, NSE:SANOFICONR's revenue was 8.78 billion, an increase of 21.24% compared to the previous year's 7.25 billion. Earnings were 2.40 billion, an increase of 32.65%.